title: Antibacterial drug discovery & development summit.
abstract: Over 100 senior researchers and managers from academic and industrial research organisations attended this 2-day annual international discovery summit on antibacterial R&D. A number of firms, particularly biotechnology firms, presented compounds that are advancing through clinical development. In addition, areas for basic research and development included metallo-beta-lactamases, ribosomal structural studies and phage-selected targets were described.
authors.affiliation: Merck Research Laboratories, Rahway, NJ, USA. John_barrett2@merck.com
authors.forename: John F
authors.initials: JF
authors.lastname: Barrett
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Dougherty
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D001424:Bacterial Infections / Q000188:drug therapy; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015195:Drug Design; D004345:Drug Industry / Q000639:trends; D006801:Humans; D012106:Research / Q000639:trends
chemical_list: D000900:Anti-Bacterial Agents